PE anti-mouse CD69 Antibody
- 产品名称:
- PE anti-mouse CD69 Antibody
- 产品类别:
- 抗体
- 产品编号:
- 104508
- 产品应用:
- 104508
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Armenian Hamster
- Immunogen
- Mouse dendritic epidermal T cell line Y245
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
The H1.2F3 antibody has been reported to augment T cell activation. Additional reported applications (for the relevant formats) include: in vitro T cell and NK cell activation1-3, immunohistochemistry4,5, and immunoprecipitation1.
This antibody has been characterized in the literature as containing a lambda (?) light chain.
- Application References
(PubMed link indicates BioLegend citation) -
- Yokoyama WM, et al. 1988. J. Immunol. 141:369. (IP)
- Sobel ES, et al. 1993. J. Immunol. 150:673.
- Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
- Zhou X, et al. 2005. J. Biol. Chem. 280:31240. (IHC)
- Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC)
- Lawson BR, et al. 2007. J. Immunol. 178:5366.
- Lee JW, et al. 2006. Nature Immunol. 8:181.
- Epardaud M, et al. 2008. Cancer Res. 15:2972. PubMed
- Jordan JM, et al. 2008. 76:3717. PubMed
- Kenna TJ, et al. 2008. Blood 111:2091. PubMed
- Ishikawa C, et al. 2013. Biochim Biophys Acta. 167:99. PubMed
- Product Citations
-
- Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
- Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
- Yuan Z, et al. 2011. Vaccine. 29:6614. PubMed
- D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
- Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
- Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
- Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
- Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
- Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
- Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
- Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
- Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed
- Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
- Mier-Aguilar C, et al. 2016. PLoS One. 11:e0168155. PubMed
- Wu J, et al. 2020. Cell Reports. 31(1):107484. PubMed
- Zhang H, et al. 2017. Leukemia. 10.1128/mBio.00226-17. PubMed
- Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
- Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
- Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
- Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
- Holan V, et al. 2010. J Immunol. 184:2124. PubMed
- Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
- Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
- Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
- Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
- Hu J, et al. 2020. Biomed Pharmacother. 127:110229. PubMed
- Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
- Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
- Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
- Huang Z, et al. 2012. J Immunol. 188:5867. PubMed
- Jackstadt R, et al. 2019. Cancer Cell. 36:319. PubMed
- Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
- Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
- Glaros V, et al. 2021. Immunity. 54:2005. PubMed
- Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
- Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
- Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
- Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
- Watanabe M, et al. 2020. Nat Commun. 4.808333333. PubMed
- Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
- Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
- Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
- Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
- Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
- Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
- Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
- Daneshmandi S, et al. 2021. Elife. 10:. PubMed
- Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
- Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
- Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
- Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
- Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
- X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
- Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
- Yan Q, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.05.006. PubMed
- Skadow M, et al. 2019. J Immunol. 203:370. PubMed
- van Geffen C, et al. 2021. Front Immunol. 12:695933. PubMed
- Passos C, et al. 2014. Food Chem. 15:161. PubMed
- Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
- Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
- Lopes N, et al. 2022. Elife. 11:. PubMed
- Jang A, et al. 2015. Life Sci . 135: 138-146. PubMed
- Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
- Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
- Schulze J, et al. 2021. Stroke. 52:2939. PubMed
- Guo X, et al. 2020. J Cell Mol Med. . PubMed
- Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
- Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
- Amantini C, et al. 2017. Oncotarget. 8:90766. PubMed
- Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
- Corrado M, et al. 2020. Cell Metab. 32:981. PubMed
- Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
- Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
- Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
- Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
- Tsai S, et al. 2018. Cell Metab. 28:922. PubMed
- RRID
- AB_313110 (BioLegend Cat. No. 104507) AB_313111 (BioLegend Cat. No. 104508)
- Structure
- C-type lectin, 27/33 kD
- Distribution
-
Activated T cells and B cells, NK cells, granulocytes, thymocytes, platelets
- Function
- Lymphocyte activation
- Cell Type
- B cells, Granulocytes, NK cells, Platelets, T cells, Thymocytes, Tregs
- Biology Area
- Costimulatory Molecules, Immunology, Innate Immunity
- Molecular Family
- CD Molecules
- Antigen References
-
1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Testi R, et al. 1994. Immunol. Today 15:479.
3. Moretta A, et al. 1991. J. Exp. Med. 174:1393.
4. Yokoyama WM, et al. 1988. J. Immunol. 141:369.
- Gene ID
- 12515 View all products for this Gene ID
- UniProt
- View information about CD69 on UniProt.org